Analysis of the rule of medication for internal administration of gout by traditional Chinese medicine based on Traditional Chinese Medicine Inheritance System

摘要

Objective:Based on the TCMIS(traditional Chinese medicine inheritance system)V2.5 to explore the rule of medication used in internal TCM(traditional Chinese medicine)for gout in the national patent network.Method:Collect the internal administrations of gout in the national patent network,and enter them into the Chinese medicine inheritance system V2.5,adopt Frequency analysis,association rules,complex system entropy clustering and other data mining methods to analyse the internal traditional formula of traditional Chinese medicine for gout.Results:By inclusion,exclusion criteria,357 formulas are screened out,involving 494 medicine,63 medicine with frequency of use≥20,and 40 commonly used medicine pairs.The core medicine are:Huangbai(Cortex Phellodendri),Cangzhu(Rhizoma Atracylodis),Niuxi(Radix Acanthopanacis Bidentatae),Yiyiren(Semen Coicis),Tufuling(Rhizoma Smilacis Glabrae),Bixie(Rhizome Dioscoreae Hypoglaucae),Gancao(Radix Glycyrrhizae),Weilingxian(Radix Clematidis),Zexie(Rhizoma Alismatis),Danggui(Radix Angelicae Sinensis),Chuanxiong(Rhizoma Chuanxiong).There are 28 new combinations and 14 new formulas.Conclusion:In the national patent network,the internal traditional Chinese medicine for gout is based on clearing away heat and dampness,activating blood circulation to dredge collaterals,which provides reference for clinical treatment of gout.